Gambaran Kepatuhan Pengobatan Pasien Diabetes di Puskesmas Kedurus Pada Era Pandemi Covid-19: Overview of Diabetes Patient Medication Adherence at the Kedurus Health Center in the Covid-19 Pandemic Era
Overview of Diabetes Patient Medication Adherence at the Kedurus Health Center in the Covid-19 Pandemic Era
Article History
Submited : June 8, 2022
Published : April 30, 2023
Diabetes is a chronic disease characterized by chronic blood glucose levels that exceed normal threshold. High blood glucose levels occur because the pancreas does not produce enough insulin or when the body is unable to use the insulin it produces effectively. Optimal diabetes management should not be interrupted and must be carried out continuously by the patient, but with Covid-19 pandemic, patient access to treatment is limited. This study aims to describe the level of compliance of diabetic patients in carrying out their treatment at the Kedurus Health Center during the Covid-19 pandemic and to determine the relationship between patient characteristics and medication adherence with diabetes treatment. This study is an observational study with a cross sectional approach conducted at the Kedurus Health Center in July-October 2021. The sample of this study were diabetic patients at the Kedurus Health Center with inclusion criteria aged 26-75 years and lived in the working area of the Kedurus Health Center. The data used in this study is secondary data obtained from the patient's medical records available at the Kedurus Health Center. The results of this study found that more than half of the respondents have poor medication adherence (54.3%) during Covid-19 pandemic era. There was no significant relationship between gender (p=0,370), age (p=0,562), distance from home to health facilities (p=0,683), and the type of oral antidiabetic drug consumed (p=0,072) with medication adherence of the diabetes patients at the Kedurus Health Center during the Covid-19 pandemic era.
2. World Health Organization. Diabetes [Internet]. 2020. 2020 [cited 2021 Apr 1]. Available from: https://www.who.int/health-topics/diabetes#tab=tab_1
3. Regina, C. C., Mu’ti, A., & Fitriany E. Systematic review tentang pengaruh obesitas terhadap kejadian komplikasi diabetes melitus tipe dua. Verdure Heal Sci J [Internet]. 2021;3(1):8–17. Available from: http://jurnal.stikesmm.ac.id/index.php/verdure/article/view/129
4. International Diabetes Federation. International Diabetes Federation: Diabetes Atlas. Ninth Edit. Vol. 266, The Lancet. International Diabetes Federation; 2019. 134–137 p.
5. Kemenkes RI. Hasil Riset Kesehatan Dasar Tahun 2018. Kementrian Kesehat RI. 2018;53(9):1689–99.
6. Wibowo MINA, Yasin NM, Kristina SA, Prabandari YS. Systematic Review : Determinan Faktor yang Memengaruhi Kepatuhan Pengobatan Pasien Diabetes Tipe 2 di Indonesia. Media Penelit dan Pengemb Kesehat. 2021;31(4):281–300.
7. WHO. Mempertahankan layanan kesehatan esensial : panduan operasional untuk konteks COVID-19. Pandu Interim [Internet]. 2020; Available from: https://www.who.int/docs/default-source/searo/indonesia/covid19/maintaining-essential-health-services---ind.pdf?sfvrsn=d8bbc480_2
8. CNN I. Menkes: Pelayanan di Puskesmas Turun Drastis Selama PandemiNo Title. Cnn Indonesia [Internet]. 2021;1. Available from: https://www.cnnindonesia.com/nasional/20210317162634-20-618726/menkes-pelayanan-di-puskesmas-turun-drastis-selama-pandemi
9. Saibi Y, Romadhon R, Nasir NM. Kepatuhan Terhadap Pengobatan Pasien Diabetes Melitus Tipe 2 di Puskesmas Jakarta Timur. J Farm Galen (Galenika J Pharmacy). 2020;6(1):94–103.
10. Notoatmodjo S. Promosi Kesehatan & Perilaku. Vol. 1, Jakarta: Rineka Cipta. 2007.
11. Asri M, Dita H, Malik R. Evaluasi Adherensi Pengobatan Pasien Diabetes Melitus Tipe 2 di Era Pandemi Covid-19. Hum Care. 2021;6(2):396–405.
12. Shimels T, Kassu RA, Bogale G, Bekele M, Getnet M, Getachew A, et al. Magnitude and associated factors of poor medication adherence among diabetic and hypertensive patients visiting public health facilities in Ethiopia during the COVID-19 pandemic. PLoS One [Internet]. 2021;16(4 April):1–13. Available from: http://dx.doi.org/10.1371/journal.pone.0249222
13. Zakaria OM, Albshr F, Yasser M, Daoud I, Zakaria OM, Albshr FA, et al. Does COVID-19 Pandemic Affect Medication Compliance Among Chronic Patients? Sapporo Med J [Internet]. 2020;54(July):7. Available from: https://www.researchgate.net/publication/344122963
14. Imelda SI. Faktor-Faktor Yang Mempengaruhi Terjadinya diabetes Melitus di Puskesmas Harapan Raya Tahun 2018. Sci J. 2019;8(1):28–39.
15. Utomo AA, R. AA, Rahmah S, Amalia R. Faktor Risiko Diabetes Mellitus Tipe 2. J Kebidanan dan Keperawatan Aisyiyah. 2020;13(2):120–7.
16. Almira N, Arifin S, Rosida L. Faktor-Faktor yang Berhubungan dengan Perilaku Kepatuhan Minum Obat Anti Diabetes pada Penderita Diabetes Mellitus Tipe 2 di Puskesmas Teluk Dalam Banjarmasin. Homeostasis. 2019;2(1):9–12.
17. Diani AP, Arifin S, Rosida L. Faktor-Faktor Yang Berhubungan Dengan Perilaku Kepatuhan Minum Obat Anti Diabetes Pada Penderita Diabetes Melitus Tipe 2 Di Puskesmas Cempaka Banjarmasin. J Mhs Pendidik Dr Hemoestasis. 2019;2(1):43–54.
18. Komariah, Rahayu S. Oral Dengan Gula Darah Puasa Pada Pasien Diabetes Melitus Tipe 2 Di Puskesmas Baturraden. J Kesehat Kusuma Husada. 2020;(Dm):41–50.
19. Julaiha S. Analisis Faktor Kepatuhan Berobat Berdasarkan Skor MMAS-8 pada Pasien Diabetes Mellitus Tipe 2. J Kesehat. 2019;10(2):203.
20. Ningrum DK. Kepatuhan Minum Obat pada Penderita Diabetes Melitus Tipe II. Higeia J Public Heal. 2020;1(3):84–94.
21. Aloudah NM, Scott NW, Aljadhey HS, Araujo-Soares V, Alrubeaan KA, Watson MC. Medication adherence among patients with type 2 diabetes: A mixed methods study. PLoS One. 2018;13(12):1–18.
22. Tominaga Y, Aomori T, Hayakawa T, Kijima N, Morisky DE, Takahashi K, et al. Possible associations of personality traits representing harm avoidance and self-directedness with medication adherence in Japanese patients with type 2 diabetes. J Pharm Heal Care Sci. 2018;4(1):1–7.
23. Lenny L, Fridalina F. Faktor-Faktor yang Berhubungan dengan Kepatuhan Berobat Jalan Pasien Diabetes Mellitus Tipe II. J Ilmu Kesehat Masy. 2018;7(02):85–93.
24. Pednekar P, Peterson A, Heller D, Brown T. Does the Distance to the Nearest Pharmacy Affect Medication Adherence Rates Among Elderly Patients with Diabetes? Value Heal. 2017;20(9):A483.
25. Rasdianah N, Martodiharjo S, Andayani TM, Hakim L. The Description of Medication Adherence for Patients of Diabetes Mellitus Type 2 in Public Health Center Yogyakarta. Indones J Clin Pharm. 2016;5(4):249–57.